These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16209992)

  • 21. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular hypertrophy, abnormal ventricular geometry and relative wall thickness are associated with increased risk of stroke in hypertensive patients among the Han Chinese.
    Wang S; Xue H; Zou Y; Sun K; Fu C; Wang H; Hui R
    Hypertens Res; 2014 Sep; 37(9):870-4. PubMed ID: 24830536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass.
    Palmieri V; de Simone G; Roman MJ; Schwartz JE; Pickering TG; Devereux RB
    Hypertension; 1999 Nov; 34(5):1032-40. PubMed ID: 10567178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of a new anthropometric index with left ventricular hypertrophy in hypertensive patients among the Han Chinese.
    Cai S; Dong J; Cheng B; Zhang A; Sun J; Li M; Su Y; Bao Q; Zhu P; Wang S
    BMC Cardiovasc Disord; 2022 Jan; 22(1):16. PubMed ID: 35081909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heritability and genetic linkage of left ventricular mass, systolic and diastolic function in hypertensive African Americans (From the GENOA Study).
    Fox ER; Klos KL; Penman AD; Blair GJ; Blossom BD; Arnett D; Devereux RB; Samdarshi T; Boerwinkle E; Mosley TH
    Am J Hypertens; 2010 Aug; 23(8):870-5. PubMed ID: 20448532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler study in echocardiographic practice.
    Cuspidi C; Negri F; Sala C; Valerio C; Mancia G
    Blood Press; 2012 Feb; 21(1):24-30. PubMed ID: 21992028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts.
    Patel SK; Wai B; Lang CC; Levin D; Palmer CNA; Parry HM; Velkoska E; Harrap SB; Srivastava PM; Burrell LM
    EBioMedicine; 2017 Apr; 18():171-178. PubMed ID: 28400202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy.
    Fu Y; Katsuya T; Matsuo A; Yamamoto K; Akasaka H; Takami Y; Iwashima Y; Sugimoto K; Ishikawa K; Ohishi M; Rakugi H; Ogihara T
    Hypertens Res; 2004 Dec; 27(12):933-8. PubMed ID: 15894833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes.
    Patel SK; Wai B; Ord M; MacIsaac RJ; Grant S; Velkoska E; Panagiotopoulos S; Jerums G; Srivastava PM; Burrell LM
    Am J Hypertens; 2012 Feb; 25(2):216-22. PubMed ID: 21993363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study.
    Tang W; Devereux RB; Rao DC; Oberman A; Hopkins PN; Kitzman DW; Arnett DK
    Am Heart J; 2002 May; 143(5):854-60. PubMed ID: 12040348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study.
    de Simone G; Palmieri V; Bella JN; Celentano A; Hong Y; Oberman A; Kitzman DW; Hopkins PN; Arnett DK; Devereux RB
    J Hypertens; 2002 Feb; 20(2):323-31. PubMed ID: 11821719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of obesity and race on left ventricular geometry in hypertensive children.
    Pruette CS; Fivush BA; Flynn JT; Brady TM
    Pediatr Nephrol; 2013 Oct; 28(10):2015-22. PubMed ID: 23703719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients.
    Muiesan ML; Salvetti M; Monteduro C; Rizzoni D; Corbellini C; Castellano M; Porteri E; Agabiti-Rosei E
    J Hypertens; 2000 Nov; 18(11):1651-6. PubMed ID: 11081779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.
    Gerdts E; Okin PM; Omvik P; Wachtell K; Dahlöf B; Hildebrandt P; Nieminen MS; Devereux RB
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):306-12. PubMed ID: 19303268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults.
    Gardin JM; Wagenknecht LE; Anton-Culver H; Flack J; Gidding S; Kurosaki T; Wong ND; Manolio TA
    Circulation; 1995 Aug; 92(3):380-7. PubMed ID: 7634452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.